InnovAge Holding Corp.

InnovAge Holding Corp. Annual Review – Simplified for Investors

Hey there! Let’s break down InnovAge’s year in plain terms. Is this company worth your attention? Let’s dive in.

---

What They Do & This Year’s Snapshot

InnovAge helps seniors stay in their homes via the PACE program, providing medical care, meals, and transportation. They’re now the largest PACE provider in the U.S., serving 7,740 seniors across 20 centers in six states.

Key updates this year:

• Revenue grew 5% to $700 million, but losses widened to $35.3 million (up from $23.2M last year).
• Membership grew 8%, but healthcare costs jumped due to higher wages and new center openings.
• 99% of revenue comes from Medicare/Medicaid, making them highly dependent on government policy.

---

Financial Health Check

• Revenue: $700M (↑5% from last year).
• Losses: $35.3M (↑52% from $23.2M last year).
• Cash: $150M on hand – enough to cover operations.
• Debt: Low ($50M), but burned $35M more than they earned.

Why losses grew:

• Labor costs rose $23.8M (nurses, drivers).
• Tax surprises: Paid $1.3M vs. a $1.4M refund last year.
• Closed a Kentucky center and sold non-core assets, costing $13.6M.

---

Wins vs. Challenges

Wins:

• Sold off senior housing assets to focus on core PACE business.
• Tech upgrades saved $5M.
• Acquired Concerto in Florida to expand reach.

Challenges:

• Labor costs up 4-5% due to wage wars.
• New Medicaid rules require eligibility checks every 6 months (could slow enrollment).
• Medicare audits now annual and stricter, raising repayment risks.

---

Risks to Watch

1. Labor inflation: Healthcare wages are rising faster than inflation.
2. Government reliance: Medicaid/Medicare pay 99% of revenue – policy changes could hurt.
3. Regulatory landmines: Stricter audits, data privacy laws, and fines for billing errors.
4. Future dilution risk: May need to raise cash by issuing more shares, diluting current investors.

---

Leadership & Strategy

• New CEO Patrick Blair is cutting costs and streamlining operations.
• Expanding in Florida and integrating pharmacy assets from the Tabula Rasa acquisition.
• Goal: 10% membership growth in 2026. Profitability possible in 1-2 years if costs stabilize.

---

The Big Picture

Opportunity: Aging population = huge demand for PACE. InnovAge dominates this niche.
Caution: Losses are growing, and regulatory risks are rising. Medicaid rule changes and audits add uncertainty.

---

Should You Invest?

Risky but intriguing. InnovAge leads a growing market, but losses and reliance on government funding are red flags. The stock could rebound if they control costs and integrate new acquisitions smoothly. However, the threat of share dilution and regulatory crackdowns make this a cautious play. Wait for signs of cost control and stable enrollment growth before jumping in.

---

Structured Data